CDMO partner

One team to turn an idea into a manufacturable product.

Cosmetic contract manufacturing (CDMO) for aesthetic medicine: feasibility, formulation, transfer, scale-up, manufacturing and documentation support under coordinated technical ownership.

01

One continuous technical path

Etternity Dermal

From brief to batch

Projects move through verifiable gates: requirements, prototype, product–container compatibility, scale-up, specifications, manufacturing and release.

We integrate formula, process, components, quality and documentation decisions to reduce late changes and preserve project traceability.

Specialist services

Three areas working as one project

Choose the closest starting point; final scope is confirmed after reviewing formula, format, market and scale.

01

Unstable-active formulation

Galenic strategies, antioxidants, chelators and process controls designed to protect sensitive actives throughout shelf life.

02

Stability and packaging compatibility

Product–container stability and compatibility studies designed to anticipate interaction, migration and performance loss.

03

Regulatory documentation and PIF

Documentation structured around the product information file, safety assessment, claims and target market.

Decision-maker question

Capabilities expressed as verifiable parameters, not promises

What cleanroom filling capabilities does Etternity Dermal offer?

Etternity Dermal operates with an ISO 7 classified cleanroom (Class C at rest) under ISO 14644-1, terminal HEPA H14 filtration and a staged differential-pressure cascade. The site integrates a sanitary Purified Water (PW) loop and filling capability for 2–50 ml Type I glass vials. Nitrogen inerting is assessed for sensitive formulas as part of process validation. The 1–5 ml Luer-Lock syringe platform is in development; every addition will be qualified, validated and technically accepted before it is presented as an available manufacturing capability.

Capability status: current vial and process systems remain project-dependent; the syringe platform is in development.

01
Problem
Environmental control for critical operations
Technical parameter
ISO 7 / Class C at rest; HEPA H14 with nominal 99.995% efficiency at 0.3 µm
Plant solution
Classified environment with terminal filtration and monitored pressure cascade.
02
Problem
Process-water quality
Technical parameter
PW: conductivity <1.3 µS/cm at 25 °C; TOC <500 ppb; endotoxins <0.25 EU/ml
Plant solution
Closed sanitary loop with recirculation and critical-parameter monitoring.
03
Problem
Product compatibility and protection
Technical parameter
2–50 ml Type I vials; N2 sweep up to 99.999% where justified by the project
Plant solution
Formula, closure, atmosphere and process are selected together before batch validation.
04
Problem
Precision in future syringe formats
Technical parameter
1–5 ml Luer-Lock; target filling tolerance ±0.5%
Plant solution
Platform in development, subject to equipment qualification, validation and product–container compatibility.
Download technical data sheetIndexable PDF · cleanroom classification, PW loop, formats and capability status
Download technical data sheet

Etternity Dermal

Define scope before committing time and cost

The evaluator turns your answers into a technical brief for an initial fit review.

Assess my project